# Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

> **NCT07143669** · — · RECRUITING · sponsor: **Blueprint Medicines Corporation** · enrollment: 450 (estimated)

## Conditions studied

- Clonal Mast Cell Disease
- KIT D816V Mutation
- Suspected KITD816V Mutated Clonal Mast Cell Disease

## Interventions

- **OTHER:** Screening

## Key facts

- **NCT ID:** NCT07143669
- **Lead sponsor:** Blueprint Medicines Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-17
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07143669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07143669, "Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07143669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*